TesoRx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TesoRx Pharma LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11224
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TesoRx Pharma LLC (TesoRx) is a pharmaceutical company that develops treatments to address unmet medical needs. The company’s product pipeline comprises TSD-001, TSD-005, TSX-011 and TSX-002. Its TSD-001is an intravesical paclitaxel for the treatment of non-muscle invasive bladder cancer. TesoRx develops products based on its novel and proprietary formulation platform, which enables drug delivery by different mechanisms or routes of administration. The company offers products for urology, oncology, and rare diseases. It partners with specialized consultants and research organizations for research and development activities. TesoRx is headquartered in Pomona, California, the US.

TesoRx Pharma LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TesoRx Pharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
TesoRx Pharma Raises USD0.7 Million in Venture Financing 10
TesoRx Pharma Raises USD10 Million in Series B-1 Financing 11
TesoRx Pharma Raises US$4 Million In Venture Financing 12
TesoRx Pharma Raises US$6 Million In Venture Financing 13
Partnerships 14
TesoRx And CoreRx Form Joint Venture For Oral Testosterone Drug 14
Licensing Agreements 15
ASKA Pharma Expands Licensing Agreement with TesoRx Pharma 15
TesoRx Pharma Enters into Licensing Agreement with Aspen Global 16
TesoRx Pharma LLC – Key Competitors 17
TesoRx Pharma LLC – Key Employees 18
TesoRx Pharma LLC – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Key Facts 2
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TesoRx Pharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TesoRx Pharma LLC, Deals By Therapy Area, 2012 to YTD 2018 8
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TesoRx Pharma Raises USD0.7 Million in Venture Financing 10
TesoRx Pharma Raises USD10 Million in Series B-1 Financing 11
TesoRx Pharma Raises US$4 Million In Venture Financing 12
TesoRx Pharma Raises US$6 Million In Venture Financing 13
TesoRx And CoreRx Form Joint Venture For Oral Testosterone Drug 14
ASKA Pharma Expands Licensing Agreement with TesoRx Pharma 15
TesoRx Pharma Enters into Licensing Agreement with Aspen Global 16
TesoRx Pharma LLC, Key Competitors 17
TesoRx Pharma LLC, Key Employees 18

List of Figures
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[TesoRx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Delaware Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Delaware Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • ROHA Dyechem Pvt. Ltd.:戦略・SWOT・企業財務分析
    ROHA Dyechem Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary ROHA Dyechem Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vestas Wind Systems AS (VWS):企業の財務・戦略的SWOT分析
    Vestas Wind Systems AS (VWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Even Construtora E Incorporadora Sa
    Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report Summary Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Daigas Group:企業の戦略・SWOT・財務分析
    Daigas Group - Strategy, SWOT and Corporate Finance Report Summary Daigas Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Emperor Energy Ltd (EMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Emperor Energy Ltd (Emperor Energy), formerly Oil Basins Ltd, is an oil and gas company that explores, produces, and develops crude oil and natural gas properties. The company explores oil and gas properties in onshore Canning Basin of Western Australia, offshore Gippsland Basin waters of so …
  • Royal FrieslandCampina N.V.:企業の戦略・SWOT・財務情報
    Royal FrieslandCampina N.V. - Strategy, SWOT and Corporate Finance Report Summary Royal FrieslandCampina N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • AstraZeneca KK-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca KK (AstraZeneca), a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic dis …
  • Pharma Mar SA (PHM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent, is indicated for the treatment of advanced …
  • Karolinska Development AB (KDEV):製薬・医療:M&Aディール及び事業提携情報
    Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up's and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care …
  • Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Arkady Novikov Restaurant Group:企業の戦略・SWOT・財務分析
    Arkady Novikov Restaurant Group - Strategy, SWOT and Corporate Finance Report Summary Arkady Novikov Restaurant Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Range Energy Resources Inc (RGO):石油・ガス:M&Aディール及び事業提携情報
    Summary Range Energy Resources Inc (Range Energy), formerly Hawkstone Energy Corp, is an oil and gas company that offers exploration and development services. The company acquires, explores and produces minerals, and oil and gas resource properties. It holds interests in Khalakan Production Sharing …
  • Vaccinex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • The Hartz Mountain Corporation:企業の戦略・SWOT・財務情報
    The Hartz Mountain Corporation - Strategy, SWOT and Corporate Finance Report Summary The Hartz Mountain Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SandRidge Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    SandRidge Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, …
  • San Miguel Corp:企業の戦略・SWOT・財務情報
    San Miguel Corp - Strategy, SWOT and Corporate Finance Report Summary San Miguel Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • 3-D Matrix Inc:企業の戦略的SWOT分析
    3-D Matrix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Citigroup Inc:戦略・SWOT・企業財務分析
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Omnicell Inc (OMCL):医療機器:M&Aディール及び事業提携情報
    Summary Omnicell Inc (Omnicell) is a provider of automation and business analytics software solutions. It provides medication control and patient safety solutions to enhance operational efficiency and patient care in acute healthcare facilities. The company offers automation solutions such as medica …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆